1. Mutations of SARS-CoV-2 RBD may alter its molecular structure to improve its infection efficiency;Alaofi;Biomolecules,2021
2. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults;Anderson;N. Engl. J. Med.,2020
3. In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion;Augusto;Allergy,2021
4. In vitro data suggest that Indian variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion;Augusto;Allergy,2021
5. Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion;Baral;Biochem. Biophys. Res. Commun.,2021